A Study of DB-1303/BNT323 vs Investigator’s Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
NCT 06018337 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 06018337 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 05914116 Brief Summary This is a dose-escalation and dose-expansion Phase 1/2a…
Read more arrow_forwardNCT 06577025 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 06256588 Brief Summary The goal of this study is to…
Read more arrow_forwardNCT 06392477 Brief Summary This is a multicenter, multiple expansion cohort, Phase…
Read more arrow_forwardNCT 06007482 Brief Summary The goal of this clinical trial is…
Read more arrow_forwardNCT 06064877 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 04565275 Brief Summary This is a multi-center, open-label, phase I/II clinical…
Read more arrow_forwardNCT 05985083 Brief Summary This is a first-in-human (FIH), open-label, multi-center, phase…
Read more arrow_forwardNCT 05818683 Brief Summary The purpose of this study is to…
Read more arrow_forward